Does that fact that the article says, "MedinCell develops several long-acting injectable formulations of ivermectin, the most advanced aims at preventing infection from Covid-19 and its mutants for several months" count for anything?
Of course not.
It means nothing to the FFRoctors.
See my post #9
From the linked study....
Clinical trial validates the safety of ivermectin taken daily in oral form, to simulate the continuous release of the active substance by a long-acting injection.
“All our programs are developed in accordance with the highest ethical standards and on the basis of reliable scientific principles with a view to potential massive deployment. Proving the safety of ivermectin in regular daily administration over a long period was an essential step for our ivermectin programs, in particular mdc-TTG in Covid-19,” said Joël Richard, Chief Development Officer at MedinCell.
After study completion and in regard of the expert review conducted by Professor Jacques Descotes1 (March 2021), the safety profile of ivermectin supports the progress of MedinCell programs using this molecule, in particular mdc-TTG against Covid-19 and mdc-STM against malaria.
Covid-19: The prophylactic strategy
“Our hypotheses are being confirmed, says Christophe Douat, CEO of MedinCell: the pandemic continues, and vaccination may not be enough to stop it. The body of clinical data and scientific knowledge supporting the efficacy of ivermectin at a therapeutic dose against Covid-19, in particular as a prophylaxis, continues to grow. In this context, our treatment, based on a widely known molecule, which could be stored at room temperature and which aims to offer protection for several months after a simple injection against Covid-19 and its variants, could become a key tool of the anti-Covid arsenal. Our goal is still to have a product ready in 2022. “
Gas_dr,
The article says:
“The body of clinical data and scientific knowledge supporting the efficacy of ivermectin at a
therapeutic dose against Covid-19, in particular as a prophylaxis, continues to grow.”
And what they are developing is a time release delivery system for —ivermectin— against the covid-19:
“Currently in regulatory development, the mdc-TTG program aims to offer an injectable treatment in the form of a
pre-filled syringe, ready to use, and stable for 24 months at room temperature. MedinCell’s BEPO® technology will
allow the formation of a small subcutaneous deposit at the time of injection. It will act as a mini pump that releases
ivermectin regularly until it disappears completely.”